Specifically, PGRMC1 is overexpressed in tumours compared to healthy tissues and associates with the poor outcome of patients with breast, head and neck, hepatocellular, or renal cancer [8,9,10,11] (reviewed in [6]). Here, PGRMC1 is linked to renal carcinoma.